HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Danesh M Javeshghani Selected Research

N- ((1- ((2- (acetylthio)- 3- methyl- 1- oxobutyl)amino)- 1- cyclopentyl)carbonyl)- O- methyl- L- tyrosine ethyl ester

2/2008Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Danesh M Javeshghani Research Topics

Disease

1Stroke (Strokes)
02/2008
1Vascular Remodeling
02/2008

Drug/Important Bio-Agent (IBA)

1N- ((1- ((2- (acetylthio)- 3- methyl- 1- oxobutyl)amino)- 1- cyclopentyl)carbonyl)- O- methyl- L- tyrosine ethyl esterIBA
02/2008
1Valsartan (Vals)FDA Link
02/2008
1Angiotensin IIIBA
02/2008